Characterization of the fluorescence of the antitumor agent, mitoxantrone

Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones

K. C. Murdock, Ralph G. Child, P. F. FABIO et al. · Journal of Medicinal Chemistry · 1979 · 283 citations

Medicine, Oncology, Pharmacology +11

Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinones

Robert K. Y. Zee-Cheng, Chuan Cheng · Journal of Medicinal Chemistry · 1978 · 254 citations

Pharmacy, Medicinal Chemistry, Pharmacology +15

Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids

Jan Kapuściński, Zbigniew Darżynkiewicz, Frank Traganos et al. · Biochemical Pharmacology · 1981 · 149 citations

Medicine, Medicinal Chemistry, Pharmacology +9

Activity of a novel anthracenedione, 1,4-dihydroxy-5,8-bis(((2-[(2-hydroxyethyl)amino]ethyl)amino])-9,10-anthracenedione dihydrochloride, against experimental tumors in mice.

Roslyn E. Wallace, K. C. Murdock, Robert B. Angier et al. · PubMed · 1979 · 149 citations

Medicine, Oncology, Pharmacology +9

Characteristics of the binding of the anticancer agents mitoxantrone and ametantrone and related structures to deoxyribonucleic acids

J. William Lown, A. Richard Morgan, Shau Fong Yen et al. · Biochemistry · 1985 · 142 citations

Medicine, Oncology, Pharmacology +8